Patient harm from cardiovascular medications
Open Access
- 1 January 2021
- journal article
- review article
- Published by SAGE Publications in Therapeutic Advances in Drug Safety
Abstract
Medication harm can lead to hospital admission, prolonged hospital stay and poor patient outcomes. Reducing medication harm is a priority for healthcare organisations worldwide. Recent Australian studies demonstrate cardiovascular (CV) medications are a leading cause of harm. However, they appear to receive less recognition as ‘high risk’ medications compared with those classified by the medication safety acronym, ‘APINCH’ (antimicrobials, potassium, insulin, narcotics, chemotherapeutics, heparin). Our aim was to determine the scale and type of medication harm caused by CV medications in healthcare. A narrative review of adult (>16 years) medication harm literature identified from PubMed and CINAHL databases was undertaken. Studies with the primary outcome of measuring the incidence of medication harm were included. Harm caused by CV medications was described and ranked against other medication classes at four key stages of a patient’s healthcare journey. Where specified, the implicated medications and type of harm were investigated. A total of 75 studies were identified, including seven systematic reviews and three meta-analyses, with most focussing on harm causing hospital admission. CV medications were responsible for approximately 20% of medication harm; however, this proportion increased to 50% in older populations. CV medications were consistently ranked in the top five medication categories causing harm and were often listed as the leading cause. CV medications are a leading cause of medication harm, particularly in older adults, and should be the focus of harm mitigation strategies. A practical approach to generate awareness among health professionals is to incorporate ‘C’ (for CV medications) into the ‘APINCH’ acronym.Keywords
This publication has 102 references indexed in Scilit:
- Adverse drug reactions in older patients: an Italian observational prospective hospital studyDrug, Healthcare and Patient Safety, 2012
- Anticoagulation-associated Adverse Drug EventsThe American Journal of Medicine, 2011
- Prevalence of Unplanned Hospitalizations Caused by Adverse Drug Reactions in Older VeteransJournal of the American Geriatrics Society, 2011
- Incidence of Adverse Drug Events and Medication Errors in Japan: the JADE StudyJournal of General Internal Medicine, 2010
- Emergency re‐admissions to hospital due to adverse drug reactions within 1 year of the index admissionBritish Journal of Clinical Pharmacology, 2010
- Adverse Drug Reactions in Hospital In-Patients: A Prospective Analysis of 3695 Patient-EpisodesPLOS ONE, 2009
- Repeat adverse drug reactions causing hospitalization in older Australians: a population‐based longitudinal study 1980–2003British Journal of Clinical Pharmacology, 2006
- Which drugs cause preventable admissions to hospital? A systematic reviewBritish Journal of Clinical Pharmacology, 2006
- Adverse drug events occurring following hospital dischargeJournal of General Internal Medicine, 2005
- Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patientsBMJ, 2004